Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck
- 1 February 1990
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 8 (1) , 105-107
- https://doi.org/10.1007/bf00216934
Abstract
Eighteen patients are evaluable for response in a Phase II trial of Mitoxantrone for advanced adenoid cystic carcinoma of the head and neck. One patient had a complete response; there were no partial responses. Twelve patients had stable disease for 3 or more months. There was no significant anti-tumor activity of Mitoxantrone in the group of patients with adenoid cystic carcinoma, all of whom were previously heavily treated with surgery, chemotherapy and/or radiation therapy.Keywords
This publication has 3 references indexed in Scilit:
- Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.1980
- Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin:A case report with a review of the literatureCancer, 1979
- Chemotherapy of malignant major salivary gland neoplasms.A 25-year review of M.D. Anderson hospital experienceCancer, 1977